01:28 PM EDT, 04/01/2025 (MT Newswires) -- Hims & Hers Health ( HIMS ) said Tuesday it is expanding its weight loss products on its telehealth platform to include generic liraglutide and branded tirzepatide.
Tirzepatide is marketed by Eli Lilly ( LLY ) under the brand name Zepbound for obesity and Mounjaro for type 2 diabetes.
Neither Hims & Hers nor Eli Lilly ( LLY ) immediately replied to a request for comment from MT Newswires.
Shares of Hims & Hers were up more than 7% in recent trading.
Price: 31.67, Change: +2.12, Percent Change: +7.17